| AEGSX | ESMCX | AEGSX / ESMCX | |
| Total Expense Ratio | 0.86 | 2.00 | 43% |
| Annual Report Gross Expense Ratio | 0.97 | 2.19 | 44% |
| Fund Existence | 9 years | 26 years | - |
| Gain YTD | 19.352 | 11.601 | 167% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000000 | 1000 | 100,000% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 950M | 164M | 579% |
| Annual Yield % from dividends | 2.12 | 2.81 | 75% |
| Returns for 1 year | 17.20 | -17.62 | -98% |
| Returns for 3 years | 26.93 | 0.93 | 2,896% |
| Returns for 5 years | -2.19 | -14.00 | 16% |
| Returns for 10 years | N/A | 26.07 | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| GLVIX | 90.27 | 1.58 | +1.78% |
| Invesco Global Focus R6 | |||
| BMGAX | 26.25 | 0.11 | +0.42% |
| BlackRock Mid-Cap Growth Equity Inv A | |||
| RLBCX | 40.12 | 0.08 | +0.20% |
| American Funds American Balanced R-3 | |||
| VSFAX | 29.61 | -0.10 | -0.34% |
| Federated Hermes MDT Small Cap Value A | |||
| PHLQX | 50.92 | -0.59 | -1.15% |
| PGIM Jennison Health Sciences R6 | |||